Results 31 to 40 of about 91,763 (276)

Delayed Recognition of Maternal G6PD Heterozygous Status Across Prenatal and Newborn Care Interfaces

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency is the most common red blood cell enzymatic disorder worldwide. Although many heterozygotes are asymptomatic, affected neonates have an increased risk for hyperbilirubinemia and related complications.
Mona M. Makhamreh   +5 more
wiley   +1 more source

Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation. [PDF]

open access: yesPLoS ONE, 2016
BACKGROUND:Population aging is a major health concern in Asian countries and it has affected the age distribution of patients with end-stage renal disease (ESRD).
Hyungjin Cho   +5 more
doaj   +1 more source

Clinical profile of pathological Jaundice among neonates admitted in the National Referral Hospital, Bhutan

open access: yesBhutan Health Journal, 2021
Introduction: Neonatal jaundice is a common condition especially in the first week of life. There are various maternal and neonatal clinical characteristics that have been associated with pathological jaundice.
Kinzang Dechen   +3 more
doaj   +1 more source

Genetic Analysis of ABO and Rh Blood Groups in Brahmin Population of Uttar Pradesh, India” [PDF]

open access: yes, 2011
A series of glycoprotein and glycolipids on the red blood cell surface constitute blood group antigens. These are A, B, AB and O in ABO blood group system and Rh in rhesus blood group system. These antigens are genetically controlled.
Vandana V. Rai
core  

TTC21B: From Modifier to Causative Gene in Joubert Syndrome

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Biallelic pathogenic variants in TTC21B, encoding the retrograde intraflagellar transport protein IFT139, are a known cause of renal and skeletal ciliopathies. Single heterozygous variants in this gene were found to be enriched in a cohort of patients with various ciliopathy phenotypes, including three individuals with Joubert syndrome (JS), a
Valentina Serpieri   +5 more
wiley   +1 more source

Monitoring of Red Cell Donor Chimerism in Oncohematological Patients After Allogeneic Hematopoietic Stem Cell Transplantation

open access: yesКлиническая онкогематология, 2023
Background. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a definitive therapy for patients with different oncological and hematological diseases.
Mariya Viktorovna Smolnikova   +4 more
doaj   +1 more source

Serological profile and hemolytic disease in term neonates with ABO incompatibility

open access: yes, 2009
Background Hemolytic disease of the newborn (HDN) due toABO blood type incompatibility is one of the most commoncause of neonatal hyperbilirubunemia that potentially leads tobilirubin encephalopathy. Data on ABO-hemolytic disease of thenewborn (ABO-HDN),
Desiana Dharmayani   +3 more
core   +1 more source

Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation

open access: yes, 2020
Background and aim: ABO and Rh compatibility are not required between the donor and recipient for allogeneic hematopoietic stem cell transplantation (alloHSCT).
AKSU, SALİH   +6 more
core   +1 more source

Transition From Primary to Secondary School: Igniting Attendance and Engagement Among Aboriginal and Torres Strait Islander Students Through National Policy Reform

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT Australia's Closing the Gap reform aims to address disparities experienced by Aboriginal and Torres Strait Islander peoples. There are specific targets focussed on key educational transitions; yet, the transition to secondary education is not a targeted priority.
Azhar Hussain Potia   +3 more
wiley   +1 more source

Blood group incompatibility due to anti C antibody: a case report [PDF]

open access: yesمجله علمی دانشگاه علوم پزشکی کردستان, 2018
Background and Aim: One of the main goals of blood transfusion medicine is to determine the compatibility of the blood products with the patients.
Rajabnia M   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy